These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32295062)

  • 1. Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis.
    Althurwi HN; Abdel-Kader MS; Alharthy KM; Salkini MA; Albaqami FF
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
    Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
    Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatographic mass analysis and further pharmacological actions of Cymbopogon proximus essential oil.
    Al-Taweel AM; Fawzy GA; Perveen S; El Tahir KE
    Drug Res (Stuttg); 2013 Sep; 63(9):484-8. PubMed ID: 23780497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kumari S; Katare PB; Elancheran R; Nizami HL; Paramesha B; Arava S; Sarma PP; Kumar R; Mahajan D; Kumar Y; Devi R; Banerjee SK
    Oxid Med Cell Longev; 2020; 2020():7147498. PubMed ID: 32082481
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction.
    Ali SS; Mohamed SFA; Rozalei NH; Boon YW; Zainalabidin S
    Cardiovasc Toxicol; 2019 Feb; 19(1):72-81. PubMed ID: 30128816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
    Li X; Zhang ZL; Wang HF
    Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
    Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H
    Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.
    He T; Chen L; Chen Y; Han Y; Yang WQ; Jin MW
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):109-20. PubMed ID: 22183794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.
    Althurwi HN; Tse MM; Abdelhamid G; Zordoky BN; Hammock BD; El-Kadi AO
    Br J Pharmacol; 2013 Apr; 168(8):1794-807. PubMed ID: 23176298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of β-caryophyllene on mitochondrial damage and cardiac hypertrophy pathways in isoproterenol-induced myocardial infarcted rats.
    Yovas A; Stanely SP; Ponnian SMP
    Eur J Pharmacol; 2023 Aug; 952():175785. PubMed ID: 37207967
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
    Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective Potential of Cymbopogon citratus Essential Oil against Isoproterenol-induced Cardiomyocyte Hypertrophy: Possible Involvement of NLRP3 Inflammasome and Oxidative Phosphorylation Complex Subunits.
    Ding XY; Zhang H; Qiu YM; Xie MD; Wang H; Xiong ZY; Li TT; He CN; Dong W; Tang XL
    Curr Med Sci; 2024 Apr; 44(2):450-461. PubMed ID: 38639827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
    Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
    Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase.
    Lu WW; Zhao L; Zhang JS; Hou YL; Yu YR; Jia MZ; Tang CS; Qi YF
    J Hypertens; 2015 Aug; 33(8):1676-87. PubMed ID: 26136070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.
    Zhao LG; Li PL; Dai Y; Deng JL; Shan MY; Chen B; Zhang KB; Guo SD; Xu ZH
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):246-254. PubMed ID: 32433360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.